Restless Legs Syndrome

Restless Legs Syndrome

Global Restless Legs Syndrome Market to Reach US$811.8 Million by 2030

The global market for Restless Legs Syndrome estimated at US$637.7 Million in the year 2023, is expected to reach US$811.8 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Medication & Devices, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$562.9 Million by the end of the analysis period. Growth in the Surgery segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$173.7 Million While China is Forecast to Grow at 6.8% CAGR

The Restless Legs Syndrome market in the U.S. is estimated at US$173.7 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$169.5 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Key Trends and Drivers

Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological disorder characterized by an uncontrollable urge to move the legs, typically due to unpleasant sensations described as crawling, tingling, or burning. The symptoms generally occur during periods of rest or inactivity, particularly at night, and can severely disrupt sleep and reduce quality of life. RLS affects approximately 5 to 10% of adults in the U.S., with a higher prevalence in women and older adults. The exact cause of RLS is unknown, but it is believed to be associated with imbalances in dopamine, a neurotransmitter that regulates muscle movement, and possibly iron deficiency. The condition can be idiopathic (having no identified cause) or secondary to other conditions such as pregnancy, iron deficiency, or renal failure.

Treatment for RLS typically involves a combination of lifestyle changes, pharmacological treatments, and sometimes iron supplementation if deficiency is present. Lifestyle interventions include maintaining regular sleep patterns, exercising moderately, and avoiding caffeine and alcohol. Medications used are mainly dopaminergic agents that increase dopamine effects, such as pramipexole and ropinirole, but can also include gabapentin and opioids for more severe cases. While these treatments do not cure RLS, they significantly alleviate symptoms and improve sleep and quality of life. However, long-term use of dopaminergic drugs can lead to augmentation—a condition where symptoms become worse than before treatment. This paradoxical effect poses a significant challenge in chronic RLS management, necessitating periodic evaluation and adjustment of therapy.

The growth in the Restless Legs Syndrome market is driven by several factors including heightened awareness and better diagnostic practices which increase the identification and reporting of RLS cases. Advances in neurology and sleep medicine contribute to improved understanding and treatments, enhancing market growth. An aging global population prone to neurological disorders also expands the patient base for RLS treatments. Additionally, ongoing research into the pathophysiology of RLS promises the development of more targeted therapies, potentially reducing the risk of augmentation seen with current dopaminergic treatments. The market benefits from increased healthcare spending and expanding reimbursement policies for sleep disorders, encouraging the adoption of both pharmacologic and non-pharmacologic therapies. Moreover, digital health innovations, like wearable devices monitoring sleep and movement, are becoming integral in managing RLS, offering new growth opportunities for technology developers and healthcare providers alike. As the landscape of RLS treatment evolves with these advancements, the market is expected to see sustained growth, improving outcomes for patients worldwide.

Select Competitors (Total 86 Featured) -
  • Azurity Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Emalex Biosciences, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Relegs BV
  • UCB SA
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Restless Legs Syndrome - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Prevalence of Restless Legs Syndrome
Advances in Neurological Research
Growing Awareness of Restless Legs Syndrome
Development of New Therapeutic Options
Impact of Lifestyle Changes on Disease Incidence
Rising Geriatric Population
Increasing Diagnosis Rates
Adoption of Novel Drug Delivery Systems
Expansion of Research on Comorbid Conditions
Growing Investment in Drug Development
Favorable Reimbursement Policies
Technological Innovations in Diagnosis and Treatment
Market Penetration of Non-Pharmacological Therapies
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Restless Legs Syndrome Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Restless Legs Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Restless Legs Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Restless Legs Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Medication & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Medication & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Medication & Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Canada 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Japan 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: China Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: China 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Restless Legs Syndrome by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Restless Legs Syndrome by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Europe 16-Year Perspective for Restless Legs Syndrome by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 53: France Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: France Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: France 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 59: Germany Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Germany 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Italy 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 71: UK Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: UK Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: UK 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 77: Spain Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Spain 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 80: Spain Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 83: Russia Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Russia 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 86: Russia Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Restless Legs Syndrome by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Restless Legs Syndrome by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Restless Legs Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 104: Australia Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Australia 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 107: Australia Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 110: India Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: India Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: India 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 113: India Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 116: South Korea Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: South Korea 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 119: South Korea Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 128: Latin America Recent Past, Current & Future Analysis for Restless Legs Syndrome by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Restless Legs Syndrome by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Latin America 16-Year Perspective for Restless Legs Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 137: Argentina Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Argentina 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 140: Argentina Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 143: Brazil Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Brazil 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 146: Brazil Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 149: Mexico Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Mexico 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 152: Mexico Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Latin America 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 161: Middle East Recent Past, Current & Future Analysis for Restless Legs Syndrome by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Restless Legs Syndrome by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Middle East 16-Year Perspective for Restless Legs Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 170: Iran Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Iran 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 173: Iran Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 176: Israel Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Israel 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 179: Israel Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Saudi Arabia 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 188: UAE Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: UAE 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 191: UAE Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Middle East 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Restless Legs Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 200: Africa Recent Past, Current & Future Analysis for Restless Legs Syndrome by Type - Medication & Devices and Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Restless Legs Syndrome by Type - Medication & Devices and Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Africa 16-Year Perspective for Restless Legs Syndrome by Type - Percentage Breakdown of Value Sales for Medication & Devices and Surgery for the Years 2014, 2024 & 2030
TABLE 203: Africa Recent Past, Current & Future Analysis for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Restless Legs Syndrome by End-Use - Hospitals End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Restless Legs Syndrome by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Homecare End-Use and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings